Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward

Neuron

Volumn 87, Issue 5, 2015, Pages 1063-1077

  Al Hasani, Ream ^a   McCall, Jordan G ^a   Shin, Gunchul ^b   Gomez, Adrian M ^a   Schmitz, Gavin P ^a   Bernardi, Julio M ^a   Pyo, Chang O ^b   Park, Sung Il ^b   Marcinkiewcz, Catherine M ^c   Crowley, Nicole A ^c   Krashes, Michael J ^d,e,f   Lowell, Bradford B ^f   Kash, Thomas L ^c   Rogers, John A ^b   Bruchas, Michael R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Illinois at Urbana Champaign   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNORPHIN; KAPPA OPIATE RECEPTOR; DOPAMINE 2 RECEPTOR; DRD2 PROTEIN, MOUSE; PHOTOPROTEIN; PRE-PRODYNORPHIN; PROTEIN PRECURSOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSION; BRAIN NERVE CELL; BRAIN REGION; CONDITIONING; CONTROLLED STUDY; MALE; MOTIVATION; MOUSE; NERVE CELL STIMULATION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OPTOGENETICS; PHOTOSTIMULATION; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; RECEPTOR UPREGULATION; REWARD; ACTION POTENTIAL; ANIMAL; AVOIDANCE BEHAVIOR; C57BL MOUSE; CLASSIFICATION; CYTOLOGY; ELECTROSTIMULATION; GENE EXPRESSION REGULATION; GENETICS; IN VITRO STUDY; INSTRUMENTAL CONDITIONING; MAZE TEST; METABOLISM; NERVE CELL; PHYSIOLOGY; SELF STIMULATION; TIME; TRANSGENIC MOUSE; WIRELESS COMMUNICATION;

ACTION POTENTIALS; ANIMALS; AVOIDANCE LEARNING; CONDITIONING, OPERANT; DYNORPHINS; ELECTRIC STIMULATION; GENE EXPRESSION REGULATION; IN VITRO TECHNIQUES; LUMINESCENT PROTEINS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; NUCLEUS ACCUMBENS; PHOTIC STIMULATION; PROTEIN PRECURSORS; RECEPTORS, DOPAMINE D2; REWARD; SELF STIMULATION; TIME FACTORS; WIRELESS TECHNOLOGY;

EID: 84940545408     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.08.019     Document Type: Article

References (66)

1. Al-Hasani R., McCall J.G., Foshage A.M., Bruchas M.R. Locus coeruleus kappa opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism. Neuropsychopharmacology 2013, 38:2484-2497.
2. Al-Hasani R., McCall J.G., Foshage A.M., Bruchas M.R. Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism. Neuropsychopharmacology 2013, 38:2484-2497.
3. Baldo B.A., Daniel R.A., Berridge C.W., Kelley A.E. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J. Comp. Neurol. 2003, 464:220-237.
4. Bals-Kubik R., Herz A., Shippenberg T.S. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology (Berl.) 1989, 98:203-206.
5. Britt J.P., Benaliouad F., McDevitt R.A., Stuber G.D., Wise R.A., Bonci A. Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron 2012, 76:790-803.
6. Britton D.R., Koob G.F., Rivier J., Vale W. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci. 1982, 31:363-367.
7. Bruchas M.R., Land B.B., Aita M., Xu M., Barot S.K., Li S., Chavkin C. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. J. Neurosci. 2007, 27:11614-11623.
8. Bruchas M.R., Land B.B., Lemos J.C., Chavkin C. CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior. PLoS ONE 2009, 4:e8528.
9. Bruchas M.R., Land B.B., Chavkin C. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res. 2010, 1314:44-55.
10. Bruchas M.R., Schindler A.G., Shankar H., Messinger D.I., Miyatake M., Land B.B., Lemos J.C., Hagan C.E., Neumaier J.F., Quintana A., et al. Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron 2011, 71:498-511.
11. Carter M.E., Yizhar O., Chikahisa S., Nguyen H., Adamantidis A., Nishino S., Deisseroth K., de Lecea L. Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat. Neurosci. 2010, 13:1526-1533.
12. Castro D.C., Berridge K.C. Opioid hedonic hotspot in nucleus accumbens shell: mu, delta, and kappa maps for enhancement of sweetness "liking" and "wanting". J. Neurosci. 2014, 34:4239-4250.
13. Chavkin C., James I.F., Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 1982, 215:413-415.
14. Daunais J.B., Roberts D.C., McGinty J.F. Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. Neuroreport 1993, 4:543-546.
15. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. J. Neurosci. 1992, 12:3628-3641.
16. Elliott P.J., Nemeroff C.B., Kilts C.D. Evidence for a tonic facilitatory influence of substance P on dopamine release in the nucleus accumbens. Brain Res. 1986, 385:379-382.
17. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005, 8:1481-1489.
18. Fagergren P., Smith H.R., Daunais J.B., Nader M.A., Porrino L.J., Hurd Y.L. Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration. Eur. J. Neurosci. 2003, 17:2212-2218.
19. Ghazarossian V.E., Chavkin C., Goldstein A. A specific radioimmunoassay for the novel opioid peptide dynorphin. Life Sci. 1980, 27:75-86.
20. Graybiel A.M., Aosaki T., Flaherty A.W., Kimura M. The basal ganglia and adaptive motor control. Science 1994, 265:1826-1831.
21. Groenewegen H.J., Wright C.I., Beijer A.V., Voorn P. Convergence and segregation of ventral striatal inputs and outputs. Ann. N Y Acad. Sci. 1999, 877:49-63.
22. Haber S.N., Groenewegen H.J., Grove E.A., Nauta W.J. Efferent connections of the ventral pallidum: evidence of a dual striato pallidofugal pathway. J. Comp. Neurol. 1985, 235:322-335.
23. Hjelmstad G.O., Fields H.L. Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell. J. Neurophysiol. 2001, 85:1153-1158.
24. Hurd Y.L., Brown E.E., Finlay J.M., Fibiger H.C., Gerfen C.R. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Brain Res. Mol. Brain Res. 1992, 13:165-170.
25. Jeong J.-W., McCall J.G., Shin G., Zhang Y., Al-Hasani R., Kim M., Li S., Sim J.Y., Jang K.-I., Shi Y., et al. Wireless Optofluidic Systems for Programmable In Vivo Pharmacology and Optogenetics. Cell 2015, 162:662-674.
26. Kim T.I., McCall J.G., Jung Y.H., Huang X., Siuda E.R., Li Y., Song J., Song Y.M., Pao H.A., Kim R.-H., et al. Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 2013, 340:211-216.
27. Knoll A.T., Muschamp J.W., Sillivan S.E., Ferguson D., Dietz D.M., Meloni E.G., Carroll F.I., Nestler E.J., Konradi C., Carlezon W.A. Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol. Psychiatry 2011, 70:425-433.
28. Krashes M.J., Shah B.P., Madara J.C., Olson D.P., Strochlic D.E., Garfield A.S., Vong L., Pei H., Watabe-Uchida M., Uchida N., et al. An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger. Nature 2014, 507:238-242.
29. Kravitz A.V., Tye L.D., Kreitzer A.C. Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat. Neurosci. 2012, 15:816-818.
30. Kupchik Y.M., Brown R.M., Heinsbroek J.A., Lobo M.K., Schwartz D.J., Kalivas P.W. Coding the direct/indirect pathways by D1 and D2 receptors is not valid for accumbens projections. Nat. Neurosci. 2015, Published online July 27, 2015. 10.1038/nn.4068.
31. Land B.B., Bruchas M.R., Lemos J.C., Xu M., Melief E.J., Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J. Neurosci. 2008, 28:407-414.
32. Land B.B., Bruchas M.R., Schattauer S., Giardino W.J., Aita M., Messinger D., Hnasko T.S., Palmiter R.D., Chavkin C. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc. Natl. Acad. Sci. USA 2009, 106:19168-19173.
33. Lee T., Kaneko T., Shigemoto R., Nomura S., Mizuno N. Collateral projections from striatonigral neurons to substance P receptor-expressing intrinsic neurons in the striatum of the rat. J. Comp. Neurol. 1997, 388:250-264.
34. Lindholm S., Ploj K., Franck J., Nylander I. Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain. Alcohol 2000, 22:165-171.
35. Madisen L., Zwingman T.A., Sunkin S.M., Oh S.W., Zariwala H.A., Gu H., Ng L.L., Palmiter R.D., Hawrylycz M.J., Jones A.R., et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 2010, 13:133-140.
36. Martone M.E., Armstrong D.M., Young S.J., Groves P.M. Ultrastructural examination of enkephalin and substance P input to cholinergic neurons within the rat neostriatum. Brain Res. 1992, 594:253-262.
37. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol. Psychiatry 2000, 48:830-843.
38. McCall J.G., Kim T.I., Shin G., Huang X., Jung Y.H., Al-Hasani R., Omenetto F.G., Bruchas M.R., Rogers J.A. Fabrication and application of flexible, multimodal light-emitting devices for wireless optogenetics. Nat. Protoc. 2013, 8:2413-2428.
39. McCall J.G., Al-Hasani R., Siuda E.R., Hong D.Y., Norris A.J., Ford C.P., Bruchas M.R. CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety. Neuron 2015, 87:605-620.
40. Melief E.J., Miyatake M., Bruchas M.R., Chavkin C. Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proc. Natl. Acad. Sci. USA 2010, 107:11608-11613.
41. Mucha R.F., Millan M.J., Herz A. Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin. Psychopharmacology (Berl.) 1985, 86:281-285.
42. Namburi P., Beyeler A., Yorozu S., Calhoon G.G., Halbert S.A., Wichmann R., Holden S.S., Mertens K.L., Anahtar M., Felix-Ortiz A.C., et al. A circuit mechanism for differentiating positive and negative associations. Nature 2015, 520:675-678.
43. Napier T.C., Mitrovic I., Churchill L., Klitenick M.A., Lu X.Y., Kalivas P.W. Substance P in the ventral pallidum: projection from the ventral striatum, and electrophysiological and behavioral consequences of pallidal substance P. Neuroscience 1995, 69:59-70.
44. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18:9996-10015.
45. Pfeiffer A., Brantl V., Herz A., Emrich H.M. Psychotomimesis mediated by kappa opiate receptors. Science 1986, 233:774-776.
46. Pickel V.M., Joh T.H., Reis D.J. Monoamine-synthesizing enzymes in central dopaminergic, noradrenergic and serotonergic neurons. Immunocytochemical localization by light and electron microscopy. J. Histochem. Cytochem. 1976, 24. 792-306.
47. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., Reisine T. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol. Pharmacol. 1994, 45:330-334.
48. Russo S.J., Nestler E.J. The brain reward circuitry in mood disorders. Nat. Rev. Neurosci. 2013, 14:609-625.
49. Rylkova D., Shah H.P., Small E., Bruijnzeel A.W. Deficit in brain reward function and acute and protracted anxiety-like behavior after discontinuation of a chronic alcohol liquid diet in rats. Psychopharmacology (Berl.) 2009, 203:629-640.
50. Schindler A.G., Messinger D.I., Smith J.S., Shankar H., Gustin R.M., Schattauer S.S., Lemos J.C., Chavkin N.W., Hagan C.E., Neumaier J.F., Chavkin C. Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake. J. Neurosci. 2012, 32:17582-17596.
51. Schlosburg J.E., Whitfield T.W., Park P.E., Crawford E.F., George O., Vendruscolo L.F., Koob G.F. Long-term antagonism of κ opioid receptors prevents escalation of and increased motivation for heroin intake. J. Neurosci. 2013, 33:19384-19392.
52. Schlussman S.D., Zhou Y., Bailey A., Ho A., Kreek M.J. Steady-dose and escalating-dose "binge" administration of cocaine alter expression of behavioral stereotypy and striatal preprodynorphin mRNA levels in rats. Brain Res. Bull. 2005, 67:169-175.
53. Shippenberg T.S., Zapata A., Chefer V.I. Dynorphin and the pathophysiology of drug addiction. Pharmacol. Ther. 2007, 116:306-321.
54. Shirayama Y., Ishida H., Iwata M., Hazama G.-I., Kawahara R., Duman R.S. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J. Neurochem. 2004, 90:1258-1268.
55. Siuda E.R., Copits B.A., Schmidt M.J., Baird M.A., Al-Hasani R., Planer W.J., Funderburk S.C., McCall J.G., Gereau R.W., Bruchas M.R. Spatiotemporal control of opioid signaling and behavior. Neuron 2015, 86:923-935.
56. Siuda E.R., Copits B.A., Schmidt M.J., Baird M.A., Al-Hasani R., Planer W.J., Funderburk S.C., McCall J.G., Gereau R.W., Bruchas M.R. Spatiotemporal control of opioid signaling and behavior. Neuron 2015, 86:923-935.
57. Solecki W., Turek A., Kubik J., Przewlocki R. Motivational effects of opiates in conditioned place preference and aversion paradigm--a study in three inbred strains of mice. Psychopharmacology (Berl.) 2009, 207:245-255.
58. Sparrow A.M., Lowery-Gionta E.G., Pleil K.E., Li C., Sprow G.M., Cox B.R., Rinker J.A., Jijon A.M., Peňa J., Navarro M., et al. Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors. Neuropsychopharmacology 2012, 37:1409-1421.
59. Sparta D.R., Stamatakis A.M., Phillips J.L., Hovelsø N., van Zessen R., Stuber G.D. Construction of implantable optical fibers for long-term optogenetic manipulation of neural circuits. Nat. Protoc. 2012, 7:12-23.
60. Stamatakis A.M., Stuber G.D. Activation of lateral habenula inputs to the ventral midbrain promotes behavioral avoidance. Nat. Neurosci. 2012, 15:1105-1107.
61. Svingos A.L., Colago E.E., Pickel V.M. Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. J. Neurosci. 1999, 19:1804-1813.
62. Tan K.R., Yvon C., Turiault M., Mirzabekov J.J., Doehner J., Labouèbe G., Deisseroth K., Tye K.M., Lüscher C. GABA neurons of the VTA drive conditioned place aversion. Neuron 2012, 73:1173-1183.
63. Thompson R.H., Swanson L.W. Hypothesis-driven structural connectivity analysis supports network over hierarchical model of brain architecture. Proc. Natl. Acad. Sci. USA 2010, 107:15235-15239.
64. Van Bockstaele E.J., Gracy K.N., Pickel V.M. Dynorphin-immunoreactive neurons in the rat nucleus accumbens: ultrastructure and synaptic input from terminals containing substance P and/or dynorphin. J. Comp. Neurol. 1995, 351:117-133.
65. Wang F., Flanagan J., Su N., Wang L.-C., Bui S., Nielson A., Wu X., Vo H.-T., Ma X.-J., Luo Y. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn. 2012, 14:22-29.
66. Zhang S., Qi J., Li X., Wang H.-L., Britt J.P., Hoffman A.F., Bonci A., Lupica C.R., Morales M. Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons. Nat. Neurosci. 2015, 18:386-392.